Heathrow's Runway Race, Biotech Takeover Bid, and Offshore Wind Surge

The CEO of Heathrow, Thomas Woldbye, has urged the UK government to accelerate planning reforms to meet the 2029 deadline for the third runway's construction. The call highlights the pressing need for infrastructure advancements to accommodate increasing air traffic demands.

In the biotech sector, EQT has approached Oxford BioMedica, a British cell and gene therapy manufacturer, with a preliminary cash offer, signaling potential consolidation in the industry. Negotiations are currently in the early stages, with no definite agreement yet.

The UK's offshore wind sector has reached new milestones with record-breaking subsidy contracts, aiming to drive decarbonisation by 2030. This development aligns with the nation's ambitious environmental targets and promises substantial contributions to sustainable energy efforts.